268 related articles for article (PubMed ID: 18367386)
1. In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks.
Fatouros DG; Nielsen FS; Douroumis D; Hadjileontiadis LJ; Mullertz A
Eur J Pharm Biopharm; 2008 Aug; 69(3):887-98. PubMed ID: 18367386
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state.
Nielsen FS; Petersen KB; Müllertz A
Eur J Pharm Biopharm; 2008 Jun; 69(2):553-62. PubMed ID: 18294829
[TBL] [Abstract][Full Text] [Related]
3. Morphological observations on a lipid-based drug delivery system during in vitro digestion.
Fatouros DG; Bergenstahl B; Mullertz A
Eur J Pharm Sci; 2007 Jun; 31(2):85-94. PubMed ID: 17418543
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic characterization of lipid-based drug delivery systems.
Ljusberg-Wahren H; Seier Nielsen F; Brogård M; Troedsson E; Müllertz A
Int J Pharm; 2005 Jul; 298(2):328-32. PubMed ID: 15979260
[TBL] [Abstract][Full Text] [Related]
5. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
Dahan A; Hoffman A
Eur J Pharm Biopharm; 2007 Aug; 67(1):96-105. PubMed ID: 17329087
[TBL] [Abstract][Full Text] [Related]
6. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.
Cui SX; Nie SF; Li L; Wang CG; Pan WS; Sun JP
Drug Dev Ind Pharm; 2009 May; 35(5):603-11. PubMed ID: 19040178
[TBL] [Abstract][Full Text] [Related]
8. Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.
Christophersen PC; Christiansen ML; Holm R; Kristensen J; Jacobsen J; Abrahamsson B; Müllertz A
Eur J Pharm Sci; 2014 Jun; 57():232-9. PubMed ID: 24056027
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).
Thomas N; Holm R; Müllertz A; Rades T
J Control Release; 2012 May; 160(1):25-32. PubMed ID: 22405903
[TBL] [Abstract][Full Text] [Related]
10. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
Porter CJ; Pouton CW; Cuine JF; Charman WN
Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems.
Heshmati N; Cheng X; Dapat E; Sassene P; Eisenbrand G; Fricker G; Müllertz A
J Pharm Pharmacol; 2014 Nov; 66(11):1567-75. PubMed ID: 24961657
[TBL] [Abstract][Full Text] [Related]
12. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and optimization of probucol self-emulsified drug delivery system to enhance solubility and dissolution.
Zaghloul A; Khattab I; Nada A; Al-Saidan S
Pharmazie; 2008 Sep; 63(9):654-60. PubMed ID: 18819518
[TBL] [Abstract][Full Text] [Related]
14. An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation.
Parojcić J; Ibrić S; Djurić Z; Jovanović M; Corrigan OI
Eur J Pharm Sci; 2007 Mar; 30(3-4):264-72. PubMed ID: 17188851
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
Grove M; Müllertz A; Nielsen JL; Pedersen GP
Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
[TBL] [Abstract][Full Text] [Related]
16. Influence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulations.
Yap SP; Yuen KH
Int J Pharm; 2004 Aug; 281(1-2):67-78. PubMed ID: 15288344
[TBL] [Abstract][Full Text] [Related]
17. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.
Balakrishnan P; Lee BJ; Oh DH; Kim JO; Lee YI; Kim DD; Jee JP; Lee YB; Woo JS; Yong CS; Choi HG
Int J Pharm; 2009 Jun; 374(1-2):66-72. PubMed ID: 19446761
[TBL] [Abstract][Full Text] [Related]
18. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
Han SF; Yao TT; Zhang XX; Gan L; Zhu C; Yu HZ; Gan Y
Int J Pharm; 2009 Sep; 379(1):18-24. PubMed ID: 19508887
[TBL] [Abstract][Full Text] [Related]
19. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability.
Kohli K; Chopra S; Dhar D; Arora S; Khar RK
Drug Discov Today; 2010 Nov; 15(21-22):958-65. PubMed ID: 20727418
[TBL] [Abstract][Full Text] [Related]
20. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In vivo oral absorption study.
Rao SV; Yajurvedi K; Shao J
Int J Pharm; 2008 Oct; 362(1-2):16-9. PubMed ID: 18650037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
